We here demonstrate the pivotal role of CSF2RB in FLT3-ITD oncogenic signaling and cellular transformation in vitro and in vivo, suggesting it to be a rational drug target in FLT3-ITD positive AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.